To investigate whether low RBM25 levels are associated with particular AML subtypes, we carried out the aforementioned analysis on specific mutations belonging to previously defined subclasses3 in patients displaying the 10% lowest vs. highest levels of RBM25 (Supplementary Figure 6a). The gene discussed is RBM25; the disease is acute myeloid leukemia.